Shield Therapeutics plc
SHIEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $14 | $3 | $12 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $23 | $8 | $3 | $1 |
| Inventory | $6 | $3 | $1 | $2 |
| Other Curr. Assets | $3 | $6 | $3 | $2 |
| Total Curr. Assets | $38 | $31 | $10 | $17 |
| Property Plant & Equip (Net) | $0 | $1 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $18 | $17 | $12 | $27 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | -$0 | $0 |
| Total NC Assets | $20 | $18 | $12 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57 | $49 | $22 | $44 |
| Liabilities | – | – | – | – |
| Payables | $7 | $4 | $2 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $26 | $9 | $9 | -$1 |
| Total Curr. Liab. | $33 | $14 | $11 | $3 |
| LT Debt | $26 | $20 | $6 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $26 | $20 | $6 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $59 | $34 | $17 | $3 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $20 | $12 | $5 | $3 |
| Retained Earnings | -$260 | -$183 | -$201 | -$107 |
| AOCI | $0 | $27 | $0 | $30 |
| Other Equity | $239 | $156 | $201 | $115 |
| Total Equity | -$1 | $12 | $5 | $41 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $57 | $49 | $22 | $44 |
| Net Debt | $20 | $6 | $3 | -$12 |